• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Design Therapeutics Inc (NQ: DSGN )

    3.650 UNCHANGED
    Streaming Delayed Price Updated: 4:15 PM EDT, May 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.650
    Bid (Size) 1.700 (5)
    Ask (Size) 4.000 (1)
    Prev. Close 3.650
    Today's Range 3.650 - 3.650
    52wk Range 1.940 - 8.470
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023
    DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace

    Performance

    YTD
    +43.70%
    +43.70%
    1 Month
    -5.68%
    -5.68%
    3 Month
    +51.45%
    +51.45%
    6 Month
    +74.64%
    +74.64%
    1 Year
    -49.24%
    -49.24%

    More News

    Read More
    Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 19, 2024
    Via Benzinga
    Earnings Preview For Design Therapeutics
    Via Benzinga
    Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments
    Via Benzinga
    Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Shares of Design Therapeutics Are Plummeting on Tuesday
    Via The Motley Fool
    Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
    Via Benzinga
    Dow Falls Over 200 Points; US Retail Sales Top Expectations
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Is Design Therapeutics Stock Moving Lower Today?
    Via Benzinga
    Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Exposures Product Safety
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.